First Advantage Co. (NYSE:FA) Given Average Recommendation of “Hold” by Brokerages

Shares of First Advantage Co. (NYSE:FA) have received a consensus rating of “Hold” from the seven analysts that are currently covering the firm, Marketbeat Ratings reports. Five investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $20.25.

Several analysts have recently issued reports on the company. Needham & Company LLC reiterated a “hold” rating on shares of First Advantage in a research note on Thursday. Barclays raised their price target on First Advantage from $15.00 to $18.00 and gave the company an “equal weight” rating in a research note on Thursday, May 29th. Finally, Royal Bank Of Canada cut First Advantage from an “outperform” rating to a “sector perform” rating and set a $20.00 price target on the stock. in a research note on Friday, May 9th.

Institutional Trading of First Advantage

Hedge funds and other institutional investors have recently bought and sold shares of the business. Nuveen Asset Management LLC raised its stake in First Advantage by 21.5% in the fourth quarter. Nuveen Asset Management LLC now owns 237,848 shares of the company’s stock valued at $4,455,000 after buying an additional 42,150 shares in the last quarter. Oppenheimer Asset Management Inc. raised its stake in First Advantage by 26.4% in the first quarter. Oppenheimer Asset Management Inc. now owns 24,811 shares of the company’s stock valued at $350,000 after buying an additional 5,185 shares in the last quarter. Rhumbline Advisers raised its stake in First Advantage by 10.8% in the first quarter. Rhumbline Advisers now owns 87,194 shares of the company’s stock valued at $1,229,000 after buying an additional 8,498 shares in the last quarter. Mutual of America Capital Management LLC increased its position in shares of First Advantage by 5.4% during the first quarter. Mutual of America Capital Management LLC now owns 1,136,993 shares of the company’s stock worth $16,020,000 after purchasing an additional 58,220 shares in the last quarter. Finally, The Manufacturers Life Insurance Company increased its position in shares of First Advantage by 16.4% during the fourth quarter. The Manufacturers Life Insurance Company now owns 37,054 shares of the company’s stock worth $694,000 after purchasing an additional 5,208 shares in the last quarter. 94.91% of the stock is currently owned by institutional investors and hedge funds.

First Advantage Stock Up 4.9%

Shares of NYSE FA opened at $17.12 on Friday. The stock has a market cap of $2.98 billion, a P/E ratio of 570.67 and a beta of 1.24. The company has a current ratio of 3.85, a quick ratio of 3.85 and a debt-to-equity ratio of 0.61. First Advantage has a 12-month low of $12.32 and a 12-month high of $20.79. The business’s fifty day simple moving average is $17.07 and its 200-day simple moving average is $16.33.

First Advantage (NYSE:FA) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.03. First Advantage had a return on equity of 13.16% and a net margin of 0.65%.The business’s revenue was up 111.7% compared to the same quarter last year. During the same period in the previous year, the company earned $0.21 EPS. First Advantage has set its FY 2025 guidance at 0.860-1.030 EPS. As a group, equities analysts predict that First Advantage will post 0.74 EPS for the current fiscal year.

About First Advantage

First Advantage Corporation provides employment background screening, identity, and verification solutions worldwide. It offers pre-onboarding products and solutions, such as criminal background checks, drug/health screening, extended workforce screening, FBI channeling, identity checks and biometric fraud mitigation tools, education/work history verification, driver records and compliance, healthcare credentials, executive screening, and other screening products.